Status:
UNKNOWN
Effect of Dexmedetomidine on Renal Function and Delayed Graft Function After Kidney Transplantation
Lead Sponsor:
Yonsei University
Conditions:
Kidney Transplantation
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The purpose of this study is to elucidate the effect of dexmedetomidine on renal function and delayed graft function after kidney transplantation
Eligibility Criteria
Inclusion
- adult (20-80 years old)
- patients undergoing elective kidney transplantation
Exclusion
- emergency surgery
- severe sinus bradycardia (\<50 beats per min \[bpm\])
- second-degree or third-degree heart block
- decreased heart function (EF \<30%)
- acute myocardial ischemia
- serious hepatic dysfunction (Child-Pugh class C)
- patients with known or suspected severe adverse reactions to DEX (or clonidine)
- treatment with clonidine or dexmedetomidine in the past 30 days
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 28 2019
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03327389
Start Date
November 1 2017
End Date
September 28 2019
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
Seoul, South Korea, 03722